These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20041828)

  • 1. Muscular dystrophies: histology, immunohistochemistry, molecular genetics and management.
    Costanza L; Moggio M
    Curr Pharm Des; 2010; 16(8):978-87. PubMed ID: 20041828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscular dystrophy: from pathogenesis to strategy.
    Hsu YD
    Acta Neurol Taiwan; 2004 Jun; 13(2):50-8. PubMed ID: 15478675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-sarcolemmal muscular dystrophies.
    Brown SC; Muntoni F; Sewry CA
    Brain Pathol; 2001 Apr; 11(2):193-205. PubMed ID: 11303795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle diseases: the muscular dystrophies.
    McNally EM; Pytel P
    Annu Rev Pathol; 2007; 2():87-109. PubMed ID: 18039094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular therapies in muscular dystrophies].
    Walter MC; Reilich P
    Fortschr Neurol Psychiatr; 2018 Sep; 86(9):535-542. PubMed ID: 30248686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Muscular dystrophies].
    Neuen-Jacob E
    Pathologe; 2009 Sep; 30(5):357-64. PubMed ID: 19669147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell therapies to treat muscular dystrophy: progress to date.
    Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
    BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited myopathies and muscular dystrophies.
    Cardamone M; Darras BT; Ryan MM
    Semin Neurol; 2008 Apr; 28(2):250-9. PubMed ID: 18351526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Strategies of Muscular Dystrophy Therapeutics: An Overview.
    Lim KRQ; Yokota T
    Methods Mol Biol; 2023; 2587():3-30. PubMed ID: 36401021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell therapy for muscular dystrophies.
    Biressi S; Filareto A; Rando TA
    J Clin Invest; 2020 Nov; 130(11):5652-5664. PubMed ID: 32946430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle.
    Patel K; Amthor H
    Neuromuscul Disord; 2005 Feb; 15(2):117-26. PubMed ID: 15694133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limb-girdle muscular dystrophies.
    Piccolo F; Moore SA; Mathews KD; Campbell KP
    Adv Neurol; 2002; 88():273-91. PubMed ID: 11908231
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging strategies for cell and gene therapy of the muscular dystrophies.
    Muir LA; Chamberlain JS
    Expert Rev Mol Med; 2009 Jun; 11():e18. PubMed ID: 19555515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome- and Cell-Based Strategies in Therapy of Muscular Dystrophies.
    Saada YB; Dib C; Lipinski M; Vassetzky YS
    Biochemistry (Mosc); 2016 Jul; 81(7):678-90. PubMed ID: 27449614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal muscle in health and disease.
    Morgan J; Partridge T
    Dis Model Mech; 2020 Feb; 13(2):. PubMed ID: 32066552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current advances in cell therapy strategies for muscular dystrophies.
    Negroni E; Vallese D; Vilquin JT; Butler-Browne G; Mouly V; Trollet C
    Expert Opin Biol Ther; 2011 Feb; 11(2):157-76. PubMed ID: 21219234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies.
    Abati E; Sclarandi E; Comi GP; Parente V; Corti S
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosis development in early-onset muscular dystrophies: Mechanisms and translational implications.
    Serrano AL; Muñoz-Cánoves P
    Semin Cell Dev Biol; 2017 Apr; 64():181-190. PubMed ID: 27670721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CRISPR-Cas9 for muscle dystrophies].
    Ballouhey O; Bartoli M; Levy N
    Med Sci (Paris); 2020 Apr; 36(4):358-366. PubMed ID: 32356712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
    Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.